← The Wire
NVAXNasdaq
NOVAVAX INC
Biological Products, (No Diagnostic Substances) · DE · CIK 1000694
Novavax develops vaccines and adjuvants to address global health challenges
$1.46B
Market cap
$9.36
Last close
+5.4%
1D
+4.0%
5D
4.0M
Volume
Price · last 39 sessions+16.6%
May 4L $8.03 · H $11.09Jun 29
344
Total filings
Jun 23, 2026
Last filing
12/31
Fiscal year end
10-K10-KFeb 26, 202610-K10-KFeb 27, 202510-K10-KFeb 28, 202410-K10-KFeb 28, 202310-K10-KMar 1, 202210-K10-KMar 1, 202110-KFORM 10-KMar 11, 202010-KFORM 10-KMar 18, 201910-KFORM 10-KMar 14, 201810-KFORM 10-KFeb 27, 201710-KFORM 10-KFeb 29, 201610-KFORM 10-KFeb 27, 201510-K10-KMar 12, 201410-KFORM 10-KMar 12, 2013
In the News
Coverage (30d): 1 reputable article.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance